Changes of Pituitary Gland Volume in Kennedy Disease

REFERENCES

1. 1.↵
   1. Kennedy WR,
   2. Alter M,
   3. Sung JH

   . Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 1968;18:671–80

   CrossRef
2. 2.↵
   1. Sobue G,
   2. Hashizume Y,
   3. Mukai E,
   4. et al

   . X-linked recessive bulbospinal neuronopathy: a clinicopathological study. Brain 1989;112(Pt 1):209–32

   Abstract/FREE Full Text
3. 3.↵
   1. Dejager S,
   2. Bry-Gauillard H,
   3. Bruckert E,
   4. et al

   . A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab 2002;87:3893–901

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Battaglia F,
   2. Le Galudec V,
   3. Cossee M,
   4. et al

   . Kennedy's disease initially manifesting as an endocrine disorder. J Clin Neuromuscul Dis 2003;4:165–67

   CrossRefPubMed
5. 5.↵
   1. Castillo M

   . Pituitary gland: development, normal appearances, and magnetic resonance imaging protocols. Top Magn Reson Imaging 2005;16:259–68

   CrossRefPubMed
6. 6.↵
   1. Rennert J,
   2. Doerfler A

   . Imaging of sellar and parasellar lesions. Clin Neurol Neurosurg 2007;109:111–24

   CrossRefPubMed
7. 7.↵
   1. Miki Y,
   2. Matsuo M,
   3. Nishizawa S,
   4. et al

   . Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology 1990;177:35–38

   PubMed
8. 8.↵
   1. Portman O,
   2. Flemming S,
   3. Cox JP,
   4. et al

   . Magnetic resonance imaging of the normal pituitary gland using ultrashort TE (UTE) pulse sequences (REV 1.0). Neuroradiology 2008;50:213–20

   CrossRefPubMed
9. 9.↵
   1. Amar AP,
   2. Weiss MH

   . Pituitary anatomy and physiology. Neurosurg Clin N Am 2003;14:11–23

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Kuroiwa T,
    2. Okabe Y,
    3. Hasuo K,
    4. et al

    . MR imaging of pituitary hypertrophy due to juvenile primary hypothyroidism: a case report. Clin Imaging 1991;15:202–05

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Woods RP

    . Multitracer: a Java-based tool for anatomic delineation of grayscale volumetric images. Neuroimage 2003;19:1829–34

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Parodi S,
    2. Pennuto M

    . Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Front Neuroendocinol 2011;32:416–25

    CrossRef
13. 13.↵
    1. Fischbeck KH

    . Polyglutamine expansion neurodegenerative disease. Brain Res Bull 2001;56:161–63

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Merry DE

    . Molecular pathogenesis of spinal and bulbar muscular atrophy. Brain Res Bull 2001;56:203–07

    CrossRefPubMed
15. 15.↵
    1. Barkhaus PE,
    2. Kennedy WR,
    3. Stern LZ,
    4. et al

    . Hereditary proximal spinal and bulbar motor neuron disease of late onset: a report of six cases. Arch Neurol 1982;39:112–16

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Harding AE,
    2. Thomas PK,
    3. Baraitser M,
    4. et al

    . X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 1982;45:1012–19

    Abstract/FREE Full Text
17. 17.↵
    1. Thomas PS Jr.,
    2. Fraley GS,
    3. Damian V,
    4. et al

    . Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet 2006;15:2225–38

    Abstract/FREE Full Text
18. 18.↵
    1. Atsuta N,
    2. Watanabe H,
    3. Ito M,
    4. et al

    . Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006;129(Pt 6):1446–55

    Abstract/FREE Full Text
19. 19.↵
    1. Sheckter CB,
    2. Matsumoto AM,
    3. Bremner WJ

    . Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary. J Clin Endocrinol Metab 1989;68:397–401

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Ahmed SF,
    2. Cheng A,
    3. Hughes IA

    . Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome. Arch Dis Child 1999;80:324–29

    Abstract/FREE Full Text
21. 21.↵
    1. Sobue G,
    2. Doyu M,
    3. Morishima T,
    4. et al

    . Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy. J Neurol Sci 1994;121:167–71

    CrossRefPubMed
22. 22.↵
    1. Elster AD,
    2. Chen MY,
    3. Williams DW 3rd.,
    4. et al

    . Pituitary gland: MR imaging of physiologic hypertrophy in adolescence. Radiology 1990;174(3 Pt 1):681–85

    PubMedWeb of Science
23. 23.↵
    1. Shinkawa O,
    2. Furuhashi N,
    3. Fukaya T,
    4. et al

    . Changes of serum gonadotropin levels and sex differences in premature and mature infant during neonatal life. J Clin Endocrinol Metab 1983;56:1327–31

    CrossRefPubMed
24. 24.↵
    1. Ikram MF,
    2. Sajjad Z,
    3. Shokh IS,
    4. et al

    . Pituitary gland volume on magnetic resonance imaging: normative observations. Pak J Neurol Sci 2007;2:141–44
25. 25.↵
    1. Tsunoda A,
    2. Okuda O,
    3. Sato K

    . MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol 1997;18:551–54

    Abstract
26. 26.↵
    1. Renz DM,
    2. Hahn HK,
    3. Schmidt P,
    4. et al

    . Accuracy and reproducibility of a novel semi-automatic segmentation technique for MR volumetry of the pituitary gland. Neuroradiology 2011;53:233–44

    CrossRefPubMed
27. 27.↵
    1. Roldan-Valadez E,
    2. Garcia-Ulloa AC,
    3. Gonzalez-Gutierrez O,
    4. et al

    . 3D volumetry comparison using 3T magnetic resonance imaging between normal and adenoma-containing pituitary glands. Neurol India 2011;59:696–99

    CrossRefPubMed